0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 21-40 of 767 Articles
JAMA Oncology | 
Editorial |  ONLINE FIRST
William D. Dupont, PhD; Jeffrey D. Blume, PhD; Jeffrey R. Smith, MD, PhD
JAMA Oncol. Published online May 26, 2016. doi:10.1001/jamaoncol.2016.0878

JAMA Oncology | 
From The JAMA Network |  ONLINE FIRST
Pamela N. Munster, MD
JAMA Oncol. Published online May 26, 2016. doi:10.1001/jamaoncol.2016.0614

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Paige Maas, PhD; Myrto Barrdahl, PhD; Amit D. Joshi, PhD; et al.
JAMA Oncol. Published online May 26, 2016. doi:10.1001/jamaoncol.2016.1025
Includes: Supplemental Content

JAMA | 
Medical News & Perspectives | 
Julie A. Jacob, MA
JAMA. 2016;315(20):2154-2156. doi:10.1001/jama.2016.3584.

JAMA | 
Viewpoint | 
Douglas A. Corley, MD, PhD; Jennifer S. Haas, MD, MSc; Sarah Kobrin, PhD, MPH
JAMA. 2016;315(19):2067-2068. doi:10.1001/jama.2016.3067.
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Robert Zachariae, DMSc
JAMA Oncol. Published online May 12, 2016. doi:10.1001/jamaoncol.2016.0713

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Heather Greenlee, ND, PhD; Alfred I. Neugut, MD, PhD; Laura Falci, MPH; et al.
JAMA Oncol. Published online May 12, 2016. doi:10.1001/jamaoncol.2016.0685
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Corey Speers, MD, PhD; Lori J. Pierce, MD
JAMA Oncol. Published online May 12, 2016. doi:10.1001/jamaoncol.2015.5805

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Vivek Verma, MD; Sushil Beriwal, MD
JAMA Oncol. Published online May 12, 2016. doi:10.1001/jamaoncol.2015.5810

JAMA | 
Editorial | 
Elizabeth S. Burnside, MD, MPH, MS; Edward A. Sickles, MD; Stephen W. Duffy, PhD
JAMA. 2016;315(18):1951-1953. doi:10.1001/jama.2016.4530.

JAMA | 
Original Investigation | 
Sian Taylor-Phillips, PhD; Matthew G. Wallis, FRCR; David Jenkinson, PhD; et al.
JAMA. 2016;315(18):1956-1965. doi:10.1001/jama.2016.5257.
Includes: CME, Supplemental Content

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2016;315(17):1825. doi:10.1001/jama.2016.4946.

JAMA Oncology | 
Research Letter | 
Brian J. Zikmund-Fisher, PhD; Nancy K. Janz, PhD; Sarah T. Hawley, PhD, MPH; et al.
JAMA Oncol. 2016;2(5):684-686. doi:10.1001/jamaoncol.2015.6416.

JAMA Surgery | 
Invited Commentary | 
Lisa A. Newman, MD, MPH
JAMA Surg. 2016;151(5):431. doi:10.1001/jamasurg.2015.4507.

JAMA Surgery | 
Original Investigation | 
Alexandra Thomas, MD; Seema A. Khan, MD; Elizabeth A. Chrischilles, PhD; et al.
JAMA Surg. 2016;151(5):424-431. doi:10.1001/jamasurg.2015.4539.
Includes: Supplemental Content

JAMA | 
Research Letter | 
Elizabeth A. Rafferty, MD; Melissa A. Durand, MD; Emily F. Conant, MD; et al.
JAMA. 2016;315(16):1784-1786. doi:10.1001/jama.2016.1708.

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Anne F. Schott, MD
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0446

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0350

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0339
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Reina Haque, PhD; Jiaxiao Shi, PhD; Joanne E. Schottinger, MD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0429
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD